Immunoblotting results demonstrated high expression of plasma LRG1 and low expression of APOA4 in colorectal cancer, further validating the results of plasma quantitative proteomics (Supplemental Fig. S2, C–F). The gene discussed is APOA4; the disease is colorectal cancer.